Funding for this study was provided solely by the authors and in no way supported by Cephalon. Lynn Webster, MD, is on Cephalon's speaker's bureau.
Modafinil Treatment of Opioid-Induced Sedation†
Article first published online: 5 JUN 2003
DOI: 10.1046/j.1526-4637.2003.03014.x
Additional Information
How to Cite
Webster, L., Andrews, M. and Stoddard, G. (2003), Modafinil Treatment of Opioid-Induced Sedation. Pain Medicine, 4: 135–140. doi: 10.1046/j.1526-4637.2003.03014.x
- †
Publication History
- Issue published online: 5 JUN 2003
- Article first published online: 5 JUN 2003
- Abstract
- Article
- References
- Cited By
Keywords:
- . Sedation;
- Opioids;
- Modafinil;
- Fatigue
ABSTRACT
Study Objective. The purpose of this study was to assess the efficacy of modafinil in combating opioid-induced sedation.
Design. A 1-year retrospective chart review of all patients receiving modafinil, a wake-promoting agent, to treat opioid-induced sedation. Opioid-induced sedation was measured using Epworth Sleepiness Scale (ESS).
Setting. Outpatient, private practice.
Patients. Eleven adult patients, six female and five male, being treated with opioids for chronic, nonmalignant pain.
Results. A significant decrease was observed between pretreatment and posttreatment ESS measurements during modafinil treatment.
Conclusion. The results suggest an improvement in opioid-induced sedation in patients treated for nonmalignant pain.

1526-4637/asset/olbannerleft.gif?v=1&s=f0c7d1452790cfee5b32e9d8086253bad7d99248)
1526-4637/asset/olbannerright.gif?v=1&s=36659e52e830f73ecf27c9b893115ff64d9653b1)
1526-4637/asset/cover.gif?v=1&s=05db6b10ee16a1b692fde30702b8d979c1971d9d)